Loading…

Japanese medical device maker Terumo has agreed to acquire U.K.-based OrganOx, a commercial-stage organ technology company, for approximately $1.5 billion. The acquisition marks Terumo's entry into the organ transplant market.
“Japanese medical device maker Terumo will acquire U.K.-based OrganOx, a commercial-stage organ technology company in Oxford, for approximately $1.5 billion.”asia.nikkei.com
Summarized from public sources; check the original articles before acting on it.